畢得醫藥(688073.SH)股東擬合計減持不超3%股份

Core Viewpoint - Bidu Pharmaceutical (688073.SH) announced a share reduction plan by its shareholders due to liquidity needs, involving a total of up to 336,000 shares, which represents approximately 2.6% of the company's total share capital [1] Group 1: Shareholder Reduction Plans - Shareholder Xinxin Management plans to reduce its holdings by up to 1.14% of the total share capital through block trades and 0.40% through centralized bidding [1] - Shareholder Landan Management intends to reduce its holdings by up to 0.86% through block trades and 0.40% through centralized bidding [1] - Shareholder Wu Bo plans to reduce his holdings by up to 0.20% through centralized bidding [1]